PD-1 inhibitor (adjuvant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1 inhibitor (adjuvant), covering 2025-12-02 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation [NA]